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Background: Coxiella burnetii is Gram-negative bacterium responsible for the zoonosis Q-fever. While it has an
obligate intracellular growth habit, it is able to persist for extended periods outside of a host cell and can resist
environmental conditions that would be lethal to most prokaryotes. It is these extracellular bacteria that are the
infectious stage encountered by eukaryotic hosts. The intracellular form has evolved to grow and replicate within
acidified parasitophorous vacuoles. The outer coat of C. burnetii comprises a complex lipopolysaccharide (LPS)
component that includes the unique methylated-6-deoxyhexose, virenose. Although potentially important as a
biomarker for C. burnetii, the pathway for its biosynthesis remains obscure.
Results: The 6-deoxyhexoses constitute a large family integral to the LPS of many eubacteria. It is believed that
precursors of the methylated-deoxyhexoses traverse common early biosynthetic steps as nucleotide-
monosaccharides. As a prelude to a full biosynthetic characterization, we present herein the results from
bioinformatics-based, proteomics-supported predictions of the pathway for virenose synthesis. Alternative
possibilities are considered which include both GDP-mannose and TDP-glucose as precursors.
Conclusion: We propose that biosynthesis of the unique C. burnetii biomarker, virenose, involves an early pathway
similar to that of other C-3’-methylated deoxysugars which then diverges depending upon the nucleotide-carrier
involved. The alternatives yield either the D- or L-enantiomers of virenose. Both pathways require five enzymatic
steps, beginning with either glucose-6-phosphate or mannose-6-phosphate. Our in silico results comprise a model
for virenose biosynthesis that can be directly tested. Definition of this pathway should facilitate the development of
therapeutic agents useful for treatment of Q fever, as well as allowing improvements in the methods for
diagnosing this highly infectious disease.
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Coxiella burnetii, the causative agent of Q fever in
humans, is a highly infectious intracellular bacterium
that resides in the parasitophorous vacuole of host cells
[1]. It causes several outbreaks of this zoonotic disease
each year [2,3]. Infected livestock are mainly asymptom-
atic, but under certain circumstances display infertility,
endometritis, placentitis, abortions, stillbirth, and delivery* Correspondence: viruludo@savba.sk
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distribution, and reproduction in any mediumof weak offspring [4-6]. Human Q fever generally results
from inhaling infectious aerosols produced by domestic
animals, can be either acute or chronic, and exhibits a
wide spectrum of clinical manifestations [7-11].
Coxiella have an extracellular matrix similar to that
of other Gram-negative bacteria. The outer coat of
virulent phase I C. burnetii isolates, from natural
sources or infections, is critical to evading the host
immune system and include full-length lipopolysac-
charides (LPS). It includes an O-antigen containing two
unique sugars, virenose (6-deoxy-3-C-methyl-D-gulose)
and dihydrohydroxystreptose (3-C-(hydroxymethyl) lyxose).
These sugars have been used as biomarkers of phase I C.
burnetii cells and are not present in phase II [12-17]. SerialCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Flores-Ramirez et al. Proteome Science 2012, 10:67 Page 2 of 8
http://www.proteomesci.com/content/10/1/67in vitro passage of C. burnetii in either embryonated hen
eggs or tissue culture results in cells with morphologically,
structurally, and compositionally different from phase I
[18,19]. These changes accompany a chromosomal deletion
which corresponds to one of the clusters in the genome
necessary for O-antigen biosynthesis [20,14]. Two clones,
clone I (9Mi/II/C1) and 4 (9Mi/II/C4) of the Nine Mile
strains classified as avirulent phase II, have a genomic dele-
tion of 25,997 bp and the third isolate, 9Mi/Baca, which
was derived from 9Mi/I by passing for 4,091 days in cell
cultures, has a shorter deleted region [20]. The results from
sequence analyses indicate that a group of LPS-biosynthetic
genes, including genes that encode epimerases, dehydra-
tases, and nucleotide-sugar glycosyltransferases, are part of
the deleted segment [14,20].
In our recent comparative proteomics study of phase I
and phase II of C. burnetii [21], seventeen proteins
involved in LPS biosynthesis and metabolism were iden-
tified. Nine of these were detected in phase I but not in
phase II cells, and are products of genes located in the
deleted region of the chromosome. Thus, we confidently
proposed these virulence-associated proteins are related
to biosynthesis of the LPS I biomarkers. Although, vire-
nose was found to be D-gulo enantiomer with the 4C1
ring conformation by NMR spectroscopy [16], the L-form
with 1C4 conformation have been reported previously as
well [17]. This potential ambiguity prompted us to exam-
ine the possible pathways for biosynthesis of the both
enantiomers. Herein we propose a homology-based bio-
synthetic pathway for virenose based upon bioinformatic
analyses and supported by the results from prior genomic
and proteomic analyses.
Results and discussion
The 6-deoxysugars constitute a large family of essential
components of the LPS of many eubacteria [22]. They
are produced by biosynthetic pathways which share early
steps [23,24]. During biosynthesis, the monosaccharide-
precursors are activated to one of four nucleoside-
diphosphate carriers (NDP); adenosine diphosphate
(ADP), thymidine diphosphate (TDP), guanosine diphos-
phate (GDP), or uridine diphosphate (UDP) [22,25] that
are then exchanged in the final step by an enzyme which
transfers the sugar to a lipid carrier, forming the O-
polysaccharide unit. The 6-deoxyhexoses can be synthe-
sized from D-glucose-6-phosphate which is a precursor
for the biosynthesis of the TDP, CDP and UDP-sugars,
or fructose-6-phosphate which is converted to mannose-
6-phosphate and serves as precursor of the GDP-sugars
[22,23,25]. The activated precursor NDP-4-keto-6-deoxy-
alpha-D-hexose is then transformed by various enzymatic
modifications (e.g., epimerization, C- and O-methylation,
deoxygenation, amination, ketoreduction, acetylation, dehy-
drations, etc.) to a great variety of deoxysugars [22,23].Glucose-6-phosphate and fructose-6-phosphate as the
initial precursors of virenose
The pathway for virenose synthesis depends upon of its en-
antiomeric and ring conformations. One version involves
activation of glucose using TDP, while in the second man-
nose is activated using GDP. In either instance, the hexose
is phosphorylated at C1 before their activation by a
nucleotidylyltransferase.
There is biochemical evidence that C. burnetii can
convert glucose to pyruvate [26-28], however, genome
sequence analysis of all six isolates has thus far failed to
identify a hexokinase responsible for converting glucose to
glucose-6-phosphate (Figure 1) or glucose-6-phosphate
and 6-phosphogluconate dehydrogenases [29]. Thus, the
first steps of both glycolysis and the pentose phosphate
pathway appear missing [29]. This might well explain the
low biosynthetic capacity and slow growth rate observed
for C. burnetii. We speculate that C. burnetii phosphory-
lates glucose via a transphosphorylation reaction involving
carbamoyl-phosphate and a phosphatidic acid phosphat-
ase family protein encoded by CBU_1267, as described for
the 9Mi/I isolate [29]. There are, of course, other as yet-
poorly defined alternatives. Possibly glucose-6-phosphate
(2) is obtained from the host cells. Both GDP-mannose,
and fructose 6-phosphate (1) or mannose-6-phosphate
(3) are potential sources of glucose-6-phosphate, invok-
ing participation of a mannose-6-phosphate isomerase
pyrophosphorylase-type or reaction (PMI-GMP; E.C.
5.3.1.8) [30] such as that found as a participant in synthesis
of the capsular polysaccharide of Pseudomonas aeruginosa,
Salmonella thyphimurium, and Xanthomonas campestris
[31,32]. The PMI-GMP enzymes posses separate domains
for the mannose isomerase (PMI) and GDP-D-mannose
pyrophosphorylase (GMP) activities [33]. A zinc-binding
motif and the catalytic amino acid residue R408 are both
characteristic of PMI activity [34]. The GMP activity is
defined in the N-terminal by the pyrophosphorylase signa-
ture sequence, GXGXR(L)-PK [34]. Based on sequence
analysis and comparison to C. burnetii genome, the PMI-
GMP activity might be catalyzed by the product of the
CBU_0671 gene, which includes both of these signatures.
It shares 45% (E value e-113), 46% (E value 3e-122), and
39% amino acid identity (E value 4e-88) with the PMI-
GMP from Salmonella enterica LT2 (AAG41744.1),
Escherichia coli (YP_002413091), and Helicobacter pylori
(YP_626781) (Additional file 1-A).
Phosphohexomutase
Both glucose-6-phosphate (2) and mannose-6-phosphate
(3) are transformed to the corresponding hexose-1-
phosphate by a phosphohexomutase [22,23,25] during
biosynthesis of deoxysugars. Phosphomannomutase/phos-
phoglucomutase (PMM/PGM; E.C. 5.4.2.8) can convert
both glucose and mannose, which are C2 epimers. In C.
Figure 1 (See legend on next page.)
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Figure 1 The proposed pathways of C. burnetii for virenose biosynthesis. The pathway might begin with either fructose-6-phosphate
(1) glucose-6-phosphate (2) or mannose-6-phosphate (3). The hexose-6-phosphates are then converted to either glucose-1-phosphate (4) or
manose-1-phosphate (5) respectively by a dual-specific α-D-phosphohexomutase. Next, thymidylyltransferase or guanylyltransferase generates
dTDP-glucose (6) or GDP-mannose (7), respectively. The activated sugars are transformed to the common intermediates in the biosynthesis of
deoxysugars dTDP-4-keto-6-deoxy-D-glucose (8) or GDP-4-keto-6-deoxy-D-mannose (9). The carbohydrates are then methylated at C3 by the
product of the TylCIII gene yielding the corresponding intermediates (10, 11). Finally, the methylated TDP intermediate is reduced by a
4-ketoreductase to form TDP-D-virenose (12). In the GDP route the intermediate GDP-3-methyl-4-keto-6-deoxy-D-idose (11) is transformed by
GDP-4-keto-6-deoxy-D-mannose epimerase/reductase to GDP-L-virenose (13) or it can be converted to GDP-D-virenose (15) by the activities of a
4-ketoreductase plus a 2-C’-epimerase.
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sequence identity (E value e-145) with the PMM/PGM
from P. aeruginosa (PDB: 1K2Y)[35] (Additional file 1-B).
It catalyzes a reversible intramolecular phosphoryl-transfer
from C6 to C1 using a Ser108 phospho-enzyme intermedi-
ate [35]. The PMM/PGM sequence of P. aeruginosa
includes the sugar binding motif GEMS(G/A) at positions
324–328 (Additional file 1-B), the catalytic residue is R421,
and residues involved in phosphate binding (Y17, K285,
R421, S423, N424, and T425) [35]. All of these sequence
motifs are conserved in the PMM/PGM sequence of C.
burnetii (CBU_0294).Nucleotide-sugar formation
Both glucose-1-phosphate (4) and mannose-1-phosphate
(5) would need to be activated to a NDP-derivate. The
activation of D-glucose-1-phosphate (4) to dTDP-D-
glucose (6) would employ D-glucose-1-phosphate thymi-
dylyltransferase (G1PTT; EC 2.7.7.24)[36], which has
been demonstrated to be involved in the synthesis of L-
rhamnose, a common component of the cell wall of
many pathogenic bacteria. The P. aeroginosa enzyme has
been named RmlA (AAG08548) [37], while the Salmon-
ella typhi enzyme was designated RfbA (NP_456644) [38].
In the actinobacteria, G1PTT is referred to as TylA1
(AAA2134), and is associated with the synthesis of mycarose,
a component of the antibiotic tylosine produced by Strepto-
myces fradiae [36] or eryA when associated with synthesis
of erytromycin by Saccharopolyspora erythraea [39].
Based on sequence analysis, the corresponding C. burnetii
gene product (CBU_1834) shares 62% (E value e-105),
61% (E value e-101), and 63% (E value 4e-107) amino acid
identity with RfbA, RmlA, and TylA1, respectively. The
primary structure of the protein encoded by the G1PTT
from P. aeroginosa contains the motif (G)GXGXR(L) and
the catalytic residues R15, K25, D110, K162 and D225, as
well as residues involved in the specificity for thymidine,
G10, Q82, and G87, which form hydrogen bonds with the
pyrimidine ring. All these residues are conserved in various
G1PTT [38] as well as in the product of the CBU_1834
gene (Additional file 1-C), although CBU_1834 is located
outside of the O-antigen gene cluster region. It has, how-
ever, been previously reported that enzymes integral tospecific pathways are often located outside of otherwise
common genic-regions [40].
If the pathway includes mannose-1-phosphate (5) as
an intermediate, it can be transformed to GDP-α-D-
mannose (7) by mannose-1-phosphate guanylyltransferase.
Results from BLAST analyses indicate similarity with the
product of CBU_0671 and the guanylyltransferase.
NDP-4-keto-6-deoxy-hexose is the key intermediate
After activation, any of the proposed intermediates
will need to be transformed into the key precursor for
all NDTP-sugars, an NDP-4-keto-6-deoxy-hexose. This
transformation involves dehydratation at C4 and C6 via
dNDP-D-hexose 4,6-dehydratase activity [22]. The dTDP-
D-glucose (6) might be transformed into dTDP-4-keto-6-
deoxy-D-glucose (8) by the TDP-glucose 4,6 dehydratase
(TGD). The product of RmlB (EC 4.2.1.46) from Salmonella
enterica serovar thypimurium [41] was first identified in
the L-rhamnose biosynthetic pathway. Homologues of this
enzyme have also been found in Streptomyces venezuelae,
E. coli K12, P. aeroginosa, Pasteurella pseudotuberculosis
and plants [41]. Sequence analysis in C. burnetii revealed
eight gene products sharing similarity with RmlB
(PDB: 1KEU) of S. typhi. The extent of sequence iden-
tity is similar among all eight proteins, CBU_0677
(27%; E value 2e-23), CBU_0844 (22%; E value 4e-21),
CBU_0689 (24%; E value 2e-15), CBU_0829 (25%; E value
1e-14), CBU_0676 (24%; E value 8e-12), CBU_0688 (21%;
E value 1e-4), CBU_1837 (22%; E value 2e-4) and
CBU_0681 (21%; E value 0.015) (Additional file 1-D). Both
CBU_0688 and CBU_0689 were located within the deleted
multigenic region thought to be necessary for the synthesis
of LPS. At the same time, CBU_0676 and CBU_0677 are
close to this region. In contrast, CBU_1837 is near to the
thymidylyl transferase gene (CBU_1834). The results from
structural studies indicate that the protein is a homodimer
that catalyzes a NAD-dependent reaction. The conserved
catalytic triad includes YXXXK (residues 167–171 in
RmlB) and a conserved motif GXXGXXG at the N-
terminus. Both motifs, together with the His residue at
position 300 which binds the ribose of dTDP, are con-
served in the candidates sequences predicted to have dTDP
D-glucose-4,6-dehydratase activity in C. burnetii. Moreover
RmlB also exhibits both structural and mechanistic
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toto, the conservation of characteristics makes it very dif-
ficult to make a bioinformatics-based prediction of which
specific single gene product is involved in the pathway.
An identical reaction is required to transform the GDP-
α-D-mannose (7) into GDP-4-keto-6-deoxy-D-mannose
(9) employing the GDP-mannose-4,6-dehydratase (GMD)
which activity was biochemically characterized in Mortierella
alpine [42]. The structure of GMD (PDB: 1RPN) from P.
aeroginosa was determined recently [43]. This enzyme is
involved in the biosynthetic pathway leading to GDP-D-
rhamnose [43], a sugar found at trace levels in the LPS of C.
burnetii [16]. The results from BLAST analyses indicate that
CBU_0689 has a 51% (E value e-105) and 50% identity
(E value 7e-91) to both GMD from E. coli (PDB; 1DB3)
[44] and P. aeroginosa (PDB; 1RPN)[43], respectively
(Additional file 1-E). This enzyme contains a characteristic
Gly-rich fingerprint, G9-XR-G-XX-5, along with the cata-
lytic residues T126, E128, Y150, and K154 (Additional file
1-E). In C. burnetii, this gene is present in the region
deleted from the phase II genome. Furthermore, the diag-
nostic catalytic T126 is replaced with a Ser residue. How-
ever, the T126S change was also found in the GMD
sequences from Aneurinibacillus thermophilus, Mycobac-
terium tuberculosis, and Methanobacterium thermoauto-
trophicum [43,44].
Methylation
Because virenose has a C-3’ methyl group, the key pre-
cursor NDP-4-keto-6-deoxy-hexose is also likely to be
methylated. Among deoxysugars, methylation reaction at
this position are mediated by NDP-hexose C-3’methyltrans-
ferases (TylCIII; E.C. 2.1.1.-) using S-adenosylmethionine
(adoMet) as the methyl donor. A role for this enzyme
has been demonstrated in the biosynthesis of L-mycarose,
erythromycin, and avilamycin by S. fradiae [45], S. ery-
thraea [46], and S. viridochromogenes [47], respectively. In
C. burnetii, the product of the CBU_0691 locus has 44%
(E value 1e-127), 44% (E value 3e-121) and 42% (E value
7e-119) amino acid identity with TylCIII from S. fradiae
(AAD41823), EryBIII from S. erythrae (YP_001102998),
and aviGI from S. viridochromogenes (AAK83176), re-
spectively. All these proteins include consensus sequence
regions which typify adoMet-dependent methyltrans-
ferases [47] (Additional file 1-F). Motif I is a 9-residue se-
quence with a conserved Gly positioned 5 residues from
the N-terminus and an Asp located 17 residues after the
C-terminus, and which mediates contact with adoMet
[48]. The D-loop, or motif II, contains an acidic residue,
either Asp or Glu, whose side-chain hydrogen makes a
bond to the ribose-hydroxyl group of AdoMet [49]. Both
motifs are present also in the sequence of the product of
CBU_0691 of C. burnetii (Additional file 1-F). Although
this enzyme has only been demonstrated to be active withTDP-sugars, there is no a priori reason that it might not
be able to accommodate a range of NDP-sugars. The
results from mechanistic studies indicate that the methyla-
tion reaction catalyzed by TylCIII proceeds with an inver-
sion of hydroxyl groups at C-3’ [45]. Thus, the equatorial
methyl group at C-3’ position and the axial C-3’ hydroxyl
group that are structural features of D- (12) and L-
virenose (13) [16,17] are reversed.
Reduction and epimerization
In the proposed biosynthetic pathway leading to TDP-
D-virenose (12), i.e., the isomer suggested by Toman
and Skultety [16] to be present in the LPS of virulent
phase I C. burnetii, only a reduction at C4 of TDP-3-
methyl-4-keto-6-deoxy-D-gulose (10) is necessary. Sev-
eral 4-ketoreductases are potentially able to provide this
reduction. They include the product of the tylCIV locus
from S. fradiae (AAD41822.1) which is involved in bio-
synthesis of mycarose[50,51], the product of the mtmU
gene from S. argillaceus associated with D-oliose and D-
olivose biosynthesis [52,53], and StrL which participates in
the synthesis of streptomycin [54]. While the sequences of
homologues of 4-ketoreductases are broadly conserved,
we were unable to find any obvious candidates within the
C. burnetii proteome. Thus, we speculate that a dual
specificity-enzyme is involved. Recently it was reported
that the enzyme encoded by TylCIII (CAK50784.1) of S.
argillaceus has 4-ketoreductase activity [53]. The C.
burnetii protein encoded by the CBU_0691 locus has 30%
identity (E value 4e-49) to TylCIII and we propose that
this is the relevant 4-ketoreductase.
In contrast, we have identified three different candi-
dates for the 4-ketoreductase that would be involved in
the synthesis of GDP-sugars. These include the GDP-4-
keto-6-deoxy-D-mannose reductase (RMD) that is involved
in several pathways [55-58], the bifunctional GMD that
catalyzes both 4,6-dehydratase and reductase reactions
leading to GDP-D-rhamnose synthesis in Klebsiella pneu-
moniae, Anaurinibacillus thermoaerophilus, and P. aerugi-
nosa [55,58], and the bifunctional GDP-4-keto-6-deoxy-D-
mannose epimerase/reductase (GMER; E.C. 1.1.1.271),
which is responsible for the last two steps of the GDP-L-
fucose synthesis in E. coli [59] and M. alpine [42]. The
pathway to GDP-L-virenose (13), i.e., the isomer suggested
by Schramek et al. [17] to be present in the LPS of virulent
phase I C. burnetii, requires both 4-ketoreductase and epi-
merase activities. The last intermediate, GDP-3-methyl-4-
keto-6-deoxy-D-idose (11), must undergo epimerization at
positions C-3 and C-5, yielding the L-enantiomer, followed
by a 4 keto-reduction catalyzed by a NADPH-dependent
GMER [60]. In C. burnetii, the product of CBU_0688
shares 45% identity (E value 5e-78) with the well-described
dual-activity GMER from E. coli (PDB: 1E6U) [60]. The
active site of this enzyme includes S107, Y136, and K140
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for epimerization reaction [60]. These amino acids/
positions are conserved in the C. burnetii sequence
(Additional file 1-G).
Although the GDP-sugar pathway to GDP-L-virenose
appears more likely, there remains the possibility that
GDP-D-virenose (15) is involved. Starting with the GDP-
3-methyl-4-keto-6-deoxy-D-idose (11), a bifunctional
GMD could provide both the dehydration and 4-
ketoreduction steps leading to GDP-3-methyl-6-deoxy-
D-idose (14) [55]. Finally, a 2-C’-epimerase would be
required to form GDP-D-virenose (15). It has not yet
been possible during the course of our bioinformatics
studies to identify a candidate for the latter enzyme
within the proteome of C. burnetii.
Recently, Narasaki et al. [61] published the results
from analysis of the first three steps of a pathway poten-
tially leading to GDP-β-D-virenose biosynthesis; fructose-
6-phosphate to mannose-6-phosphate to mannose-1-
phosphate to GDP-β-D-mannose. The enzymes involved,
phospho-mannose isomerase, phospho-mannose mutase,
GDP-mannose pyrophosphorylase, GDP-mannose 4,6-
dehydratase, and C-3’methyltransferase, are also part of
one branch of our proposed pathway. It is important to
consider, however, that while consistent with and fully
supporting our proposal these three steps are not unique
to biosynthesis of either virenose or dihydrohydroxystrep-
tose [22,25].
Conclusions
Herein we propose that biosynthesis of the unique C.
burnetii biomarker, virenose, involves a pathway similar
to that of other C-3’-methylated deoxysugars. Two alter-
native routes are provided that differ primarily in the
nucleotide-sugar involved. The alternatives yield either
the D- or L-enantiomers of virenose. Both routes require
five enzymatic steps, beginning with either glucose-6-
phosphate or mannose-6-phosphate. For the pathway start-
ing with glucose-6-phosphate and ending with D-virenose,
we propose involvement of α-D-phosphohexomutase, thy-
midyltransferase, TDP-glucose-4,6-dehydratase, NDP-hex-
ose-3-C-methyltransferase, and an enzyme with 4-keto-
reductase activity that cannot be confidently predicted
from analysis of the C. burnetii genome. Alternatively,
starting with mannose-6-phosphate we predict the involve-
ment of α-D-phosphohexomutase, guanyltransferase, GDP-
mannose-4,6-dehydratase, NDP-hexose-3-C-methyltrans-
ferase, and GDP-4-keto-6-deoxy-D-mannose epimerase/
reductase, leading to L-virenose. Our in silico results com-
prise a model for virenose biosynthesis that is entirely
plausible based upon the results of proteomic analyses
and which can be directly tested. Definition of this path-
way will facilitate the development of therapeutic agents




The protein sequences were retrieved from the UniProt
knowledge database [62] and NCBI [63] using BLAST
searches [64] with the PMI-GMP (NCBI:AAG41744.1),
PMM/PGM (PDB:1K2Y), G1PTT (NCBI:AAG08548), GMD
(PDB:1RPN), TGD (PDB:1KEU), TylCIII (NCBI:AAD41823),
and GMER (PDB:1EGU) sequences as queries. Sequences
were aligned using Clustal-W2 [65] on the European
Bioinformatics Institute’s server (http://www.ebi.ac.uk/).
Manual adjustments were made in order to maximize
similarities. Structures were retrieved from the Protein
Data Bank (PDB) [66].Additional Files
Additional file 1: Alignments of amino acid sequences of predicted
enzymes implemented in the synthesis of D- and L-virenose. (A)
Mannose-6-phosphate isomerase pyrophosphorylase (PMI-GMP). The blue
highlighting indicates the pyrophosphorylase signature sequence (N-
terminus) while the zinc-binding motif (C-terminus) is green. The R408 of
the C-terminal Zn-binding motif is involved in catalysis (in red). (B) Dual
phosphomannomutase/phosphoglucomutase (PMM/PGM). The residues
involved in phosphate binding (Y17 K285 R421 S423 N424 T425) are in
blue together with the phosphorylated S108 (according to the structure
of P aeruginosa PMM/PGM; (PDB: 1K2Y). The residues involved in sugar
binding (GEMS) are green. (C) Glucose-1-phosphate thymydylytransferase
(G1PTT). The residues participating in catalysis and those responsible for
thymidine-specificity are red and yellow respectively. The conserved
N-terminal motif GXXXXL is green. (D) DTP-D-glucose-4,6-dehydratase
(TGD). BLAST analysis against the C burnetii proteome using the TGD
from S enterica (PDB:1G1A) gives eight candidates for such activity:
CBU_0677 NAD-dependent epimerase/dehydratase family protein;
CBU_0844 capsular polysaccharide biosynthesis protein I; CBU_0689 GDP-
mannose-46-dehydratase; CBU_0829 NAD-dependent epimerase/
dehydratase family protein; CBU_0676 NAD-dependent epimerase/
dehydratase; CBU_0688 GDP-fucose synthetase; CBU_1837 putative
NAD-dependent epimerase/dehydratase family protein; and CBU_0681
conserved hypothetical protein. The results from structural studies have
shown that the latter protein is a homodimer in a NAD-dependent
reaction. The conserved catalytic triad includes YXXXK (residues 167–171
in 1KEU) in light blue and a conserved motif GXXGXXG at the N-terminus
in green are conserved in C burnetii. The H300 (yellow) which binds the
ribose of dTDP is conserved in four of the sequence candidates in C
burnetii. (E) GDP-mannose-46 dehydratase (GMD). The characteristic Gly-
rich fingerprint sequence of GILFNHEGPXRGXXFVTRK which binds NADPH
is highlighted in dark green inside this zone R185 is conserved in all
GMD sequences previously characterized (yellow). The catalytic residues
T126 Glu128 Y150 and K154 are highlighted in light red. The R35 and R43
residues in P aeroginosa comprise the RR loop which participates in the
tetrameric interface are indicated in blue. (F) NDP-hexose 3-C
methyltransferase (TylCIII). The motif I characteristic of S-
adenosylmethionine (SAM)-dependent methyltransferases is highlighted
in light green; the Gly residue of the SAM-binding site is yellow and the
motif II sequence is highlighted in blue with emphasis on the conserved
Asp residue in yellow. The Asp positioned 17 residues after motif I
thought to be important in making a contact with SAM is shown in
orange. (G) The bifunctional GDP-4-keto-6-deoxy-D-mannose epimerase/
reductase (GMER). The catalytic residues S107 Y136 and K140 are light
green the residues involved in epimerization C109 and H179 are yellow.
The characteristic N-terminal GXXGXXG motif is green.
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G1PTT: D-glucose-1-phosphate thymidylyl transferase; GMD: GDP-mannose-
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